Department of Clinical Chemistry and Laboratory Medicine, Kyushu University Hospital, 3-1-1 Maidashi, Fukuoka 812-8582, Japan Tel: +81-92-642-5752, Fax: +81-92-642-5752, E-mail: [email protected] Copyright 2022 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
P., Dong, L., & Chen, Y
Some proteins involved in inflammation, such IGFBP7, formed a conserved network in HFpEF across two independent cohorts from the PROMIS-HFpEF study and may mediate the association between comorbidity burden and echocardiographic indicators of worse haemodynamics and RV dysfunction.105 Patients with a pan-inflammatory phenotype exhibited the highest circulating levels of inflammatory mediators, more comorbidity, more HF hospitalisations, higher left-atrial volume index and NT-proBNP level, worse renal function, the highest levels of fibrotic biomarkers such IGFBP7 and the lowest functional capacity, in an HFpEF study that used unsupervised machine learning.106 Nevertheless, higher concentrations of IGFBP7 were associated with increased risk of cardiovascular events in patients from the I-PRESERVE trial, but after multivariable adjustment this association was no longer present.107 Regarding diastolic function, in a cohort of HFpEF patients IGFBP7 was elevated and associated with markers of diastolic dysfunction, HF severity and prognosis ( Table 2 ).108 In HFpEF patients randomised to receive sacubitril/valsartan versus valsartan, higher concentrations of IGFBP7 were associated with abnormalities in diastolic filling and left atrial dilation
N.SchultzS
